REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201009:nBw2jb6Ha
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 08 October 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,494,561 1.94% 465,044 0.36%
(2) Derivatives (other than options):
355,000 0.28% 388,524 0.30%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
2,849,561 2.21% 853,568 0.66%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 212.5950 USD
Purchase 30 211.1800 USD
Purchase 39 211.8500 USD
Purchase 87 213.0185 USD
Purchase 100 213.4200 USD
Purchase 113 212.9255 USD
Purchase 137 212.4100 USD
Purchase 194 213.2795 USD
Purchase 328 214.0316 USD
Purchase 377 212.2561 USD
Purchase 400 213.8934 USD
Purchase 469 212.4830 USD
Purchase 755 212.9188 USD
Purchase 991 212.5037 USD
Purchase 1,001 212.3989 USD
Purchase 2,323 211.0700 USD
Purchase 2,392 211.0940 USD
Purchase 2,470 213.3929 USD
Purchase 2,912 212.9866 USD
Purchase 3,315 212.1284 USD
Purchase 4,783 211.6721 USD
Purchase 5,709 212.3370 USD
Purchase 6,513 212.6153 USD
Purchase 6,825 213.1856 USD
Purchase 7,285 212.2352 USD
Purchase 8,726 211.7620 USD
Purchase 20,140 212.4511 USD
Sale 4 212.8900 USD
Sale 4 212.6337 USD
Sale 25 211.3500 USD
Sale 39 211.8500 USD
Sale 92 212.9000 USD
Sale 100 212.7100 USD
Sale 200 213.9167 USD
Sale 200 211.4000 USD
Sale 200 213.8700 USD
Sale 200 213.0925 USD
Sale 200 211.9250 USD
Sale 284 211.6407 USD
Sale 354 211.3815 USD
Sale 377 212.3383 USD
Sale 435 211.3667 USD
Sale 809 213.7983 USD
Sale 904 211.0387 USD
Sale 2,323 211.0700 USD
Sale 3,438 211.1551 USD
Sale 4,140 212.6633 USD
Sale 4,490 213.4660 USD
Sale 4,513 213.0299 USD
Sale 4,700 212.0182 USD
Sale 5,130 211.0849 USD
Sale 5,368 212.3337 USD
Sale 39,887 212.5101 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 9 Oct 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201009005141/en/
(https://www.businesswire.com/news/home/20201009005141/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Stock Exch Notice - Admission to Trading - 17/12/2025
AnnouncementREG - Barclays PLC - Additional Listing
AnnouncementREG - Barclays PLC - Transaction in Own Shares
AnnouncementREG - Barclays PLC - Director/PDMR Shareholding
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement